National Health Investors (NYSE:NHI - Get Free Report) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating in a note issued to investors on Wednesday.
Several other research firms also recently commented on NHI. Wells Fargo & Company upgraded National Health Investors from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $55.00 to $63.00 in a report on Monday, February 26th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of National Health Investors in a report on Tuesday, January 30th. They issued a "buy" rating and a $69.00 price objective for the company. Truist Financial raised their price target on National Health Investors from $55.00 to $58.00 and gave the company a "hold" rating in a report on Thursday, April 4th. Wedbush increased their price target on shares of National Health Investors from $64.00 to $66.00 and gave the company an "outperform" rating in a research report on Monday, March 18th. Finally, BMO Capital Markets raised National Health Investors from a "market perform" rating to an "outperform" rating and set a $67.00 price objective for the company in a research note on Tuesday, March 12th. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, National Health Investors has an average rating of "Moderate Buy" and an average target price of $60.50.
View Our Latest Stock Analysis on National Health Investors
National Health Investors Stock Performance
Shares of NHI traded down $2.64 during mid-day trading on Wednesday, hitting $58.35. 174,811 shares of the company's stock were exchanged, compared to its average volume of 176,009. National Health Investors has a 52 week low of $47.54 and a 52 week high of $62.93. The stock's 50-day simple moving average is $57.84 and its 200-day simple moving average is $54.93. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90. The firm has a market cap of $2.53 billion, a price-to-earnings ratio of 18.64 and a beta of 0.95.
Insider Buying and Selling at National Health Investors
In other National Health Investors news, Director Charlotte A. Swafford bought 10,000 shares of the firm's stock in a transaction on Tuesday, February 27th. The stock was acquired at an average price of $58.69 per share, with a total value of $586,900.00. Following the transaction, the director now owns 110,185 shares in the company, valued at $6,466,757.65. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 8.21% of the company's stock.
Institutional Trading of National Health Investors
A number of hedge funds have recently bought and sold shares of the company. Compass Wealth Management LLC bought a new stake in National Health Investors during the first quarter valued at approximately $30,000. Lazard Asset Management LLC purchased a new position in shares of National Health Investors during the 2nd quarter worth $32,000. Baystate Wealth Management LLC bought a new stake in shares of National Health Investors during the 4th quarter valued at $39,000. Advisory Services Network LLC increased its stake in shares of National Health Investors by 71.8% in the 1st quarter. Advisory Services Network LLC now owns 737 shares of the real estate investment trust's stock worth $38,000 after purchasing an additional 308 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new position in National Health Investors in the 3rd quarter worth $38,000. Hedge funds and other institutional investors own 62.51% of the company's stock.
About National Health Investors
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
